AI assistant
Sending…
VOLITIONRX LTD — Director's Dealing 2016
May 6, 2016
34395_dirs_2016-05-06_e471681a-d278-4ede-8ded-d9750a77d7e0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2016-05-04
Reporting Person: Innes Guy Archibald (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-05-04 | Warrant (Right to Buy) | $2.6 | D | 74821 | Disposed | 2016-05-10 | Common Stock (74821) | Direct |
| 2016-05-04 | Warrant (Right to Buy) | $2.6 | A | 74821 | Acquired | 2017-05-10 | Common Stock (74821) | Direct |
| 2016-05-04 | Warrant (Right to Buy) | $2.6 | D | 1786 | Disposed | 2016-05-10 | Common Stock (1786) | Indirect |
| 2016-05-04 | Warrant (Right to Buy) | $2.6 | A | 1786 | Acquired | 2017-05-10 | Common Stock (1786) | Indirect |
Footnotes
F1: The four reported transactions involved an amendment of two outstanding warrants, resulting in the deemed cancellation of the "old" warrants and the grant of two "replacement" warrants. The warrants were originally granted on May 11, 2012 with an expiration date of May 10, 2016. The expiration date of the warrants was extended one year to May 10, 2017.
F2: The foregoing warrant was placed in a bare trust, which is not a separate legal entity, of which Mr. Innes is the Trustee, for the benefit of certain minors.
More from VOLITIONRX LTD
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 13
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 23
Regulatory Filings
2026
Apr 17
Regulatory Filings
2026
Apr 1